Cardiac Biotech Solutions Inc.OTC: CBSC

CB Scientific (CBSC) Pleased to Announce the Company is Current with OTC Markets

· Issued by Cardiac Biotech Solutions Inc.
CB Scientific, Inc. (OTC PINK: CBSC), a designer, developer and manufacturer of Cannabis Analytical Tools and Devices, Cannabis Medical Delivery Systems and Personal Analytical Kits and Devises, announces today that the Company has been upgraded to Current status with OTC Markets. The Company posted its September, and December 2016 Quarterly Reports and supplemental Issuer Information and Disclosure Statements last week with OTC Markets. 

The Company has also elected to file a post-qualification amendment to its registration statement on Form 1-A, originally filed by the Company on Oct 4, 2016, qualified thereafter by the U.S. Securities and Exchange Commission on Nov 22, 2016. The post-qualification amendment will be to upgrade Company’s registration statement from Tier I to Tier II RegA+. The Company has engaged Malone Bailey LLP to audit its financials for years ending March 2016 and 2017. The financial audit is a requirement for the Tier II registration statement under Form 1-A. The Tier II registration statement under Form 1-A will allow the company to become a fully SEC Reporting company under Reg A. 

About CB Scientific, Inc.

CB Scientific (www.cbscientific.com), through its subsidiaries, designs, develops and manufactures Life Science Analytical Tools and Devices, Medical Delivery Systems, laboratory services, personal analytical kits and devises and CBD hemp oil and nutraceutical formulations for growers, care takers, dispensaries and companies worldwide. CB Scientific is continuing to develop new technologies specifically for cannabis (hemp) analytics. CB Scientific believes every product sold to patients as "Medical Quality" should be inspected for health benefits, safety, consistency, purity, potency and packaged properly for distribution. CB Scientific has worked with many of the cannabis industry leaders in the country and have also been featured in cannabis industry publications including High Times Magazine, Culture and many trade publications, on-air interviews and panel discussions across the United States. CB Scientific's focus has been the education and safety of consumers combined with innovation to put power into the hands of the patients. 
To request further information about CB Scientific, please email us at info@cbscientific.com, log onto our website at http://www.cbscientific.com or visit us on Twitter @cbscientific and Facebook at cbscientificinc.

Forward-Looking Statements

This press release may contain forward-looking statements covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products and services that we may not produce today and that meet defined specifications. When used in this press release, the words "plan," "expect," "believe," and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets. This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

Contact:
Media Contact
CB Scientific Inc.
Http://www.cbscientific.com
info@cbscientific.com
(720) 370-3554 
Twitter - @cbscientific
Facebook - cbscientificinc